Özge Can

Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas

Cemaliye Boylu Akyerli, Şirin Yüksel, Özge Can et al. · Journal of neurosurgery · 2017 · 36 citations

Medicine, Molecular Genetics, Oncology +17

IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation

Yavuz Oktay, Ege Ülgen, Özge Can et al. · Scientific Reports · 2016 · 35 citations · Full text

Medicine, Genetics, Oncology +15

Post‐translational modifications of transthyretin affect the triiodonine‐binding potential

Andrea Henze, Thomas Homann, Mustafa Serteser et al. · Journal of Cellular and Molecular Medicine · 2014 · 30 citations · Full text

Life Sciences, Biochemistry, Endocrinology +15

Lessons from the Hamster: <i>Cricetulus griseus</i> Tissue and CHO Cell Line Proteome Comparison

Kelley Heffner, George S. Yerganian, Amit Kumar et al. · Journal of Proteome Research · 2017 · 16 citations

Life Sciences, Biochemistry, Molecular Biology +17

NF-κB-Induced Upregulation of miR-548as-3p Increases Invasion of NSCLC by Targeting PTEN

Şakir Akgün, Hakan Küçüksayan, Osman N. Özeş et al. · Anti-Cancer Agents in Medicinal Chemistry · 2019 · 12 citations

Medicine, Molecular Biology, Oncology +17